BioCentury | Dec 8, 2014
Clinical News
Tretinoin gel: Phase II data
...whereas Retin-A Micro significantly increased the number of patients with erythema and dryness from baseline. Phosphagenics...
...not powered for significance. Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX, Laval, Quebec) markets Retin-A Micro. Phosphagenics Ltd....
...TPM/Retinoic Acid , TPM/Tretinoin Business: Dermatology Molecular target: Not applicable Description: Tretinoin formulated with Phosphagenics’...
...not powered for significance. Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX, Laval, Quebec) markets Retin-A Micro. Phosphagenics Ltd....
...TPM/Retinoic Acid , TPM/Tretinoin Business: Dermatology Molecular target: Not applicable Description: Tretinoin formulated with Phosphagenics’...